press center press release

ArthroCare Corporation (ARTC) President and CEO to Ring the NASDAQ Stock Market Opening Bell

Published

MEDIA ADVISORY, Oct. 26, 2006 (PRIMEZONE) --

What: Mike Baker, President & CEO of ArthroCare Corporation (ARTC) will preside over the opening bell to celebrate its 10-year listing anniversary on the NASDAQ. ArthroCare Corporation is a member of the NASDAQ Global Market Select, S&P Small Cap 600 Index and the S&P 1500 Super Composite Index. NASDAQ lists over 72% of Health Care Equipment companies. Out of 156 total Companies in the Health Care Equipment Industry, 113 list on NASDAQ. Where: NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio When: Friday October 27th, 2006 at 9:30 a.m. EDT Contacts: Howard Zar Porter Novelli 212.601.8084 howard.zar@porternovelli.com NASDAQ MarketSite: Stephanie Lowenthal; 646.441.5220

Feed Information:

The opening bell is available from 9:20 a.m. to 9:35 a.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can also be found on Waterfront fiber 1623. If you have any questions, please contact Stephanie Lowenthal at (646) 441-5220.

Photos:

To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.

About ArthroCare Corporation (ARTC):

Founded in 1993, ArthroCare Corp. (www.arthrocare.com) is a highly innovative, multi-business medical device company that develops, manufactures and markets minimally invasive surgical products. With these products, ArthroCare targets a multi-billion dollar market opportunity across several medical specialties, significantly improving existing surgical procedures and enabling new, minimally invasive procedures. Many of ArthroCare's products are based on its patented Coblation technology, which uses low-temperature radiofrequency energy to gently and precisely dissolve rather than burn soft tissue -- minimizing damage to healthy tissue. Used in more than four million surgeries worldwide, Coblation-based devices have been developed and marketed for sports medicine; spine/neurologic; ear, nose and throat (ENT); cosmetic; urologic and gynecologic procedures. ArthroCare also has added a number of novel technologies to its portfolio, including Opus Medical sports medicine, Parallax spine and Applied Therapeutics ENT products, to complement Coblation within key indications.

In This Story

NDAQ

Nasdaq Press Center

Read the latest press releases, request a press kit, and get in touch with our press team.

learn more